Multivariate

Arize AI Debuts Phoenix, the First Open Source Library for Evaluating Large Language Models

Retrieved on: 
Wednesday, April 26, 2023

BERKELEY, Calif., April 26, 2023 /PRNewswire/ -- Arize AI, a market leader in machine learning observability, debuted deeper support on the Arize platform for generative AI and a first-of-its-kind open source observability library for evaluating large language models (LLMs) at its Arize:Observe 2023 summit.

Key Points: 
  • BERKELEY, Calif., April 26, 2023 /PRNewswire/ -- Arize AI, a market leader in machine learning observability, debuted deeper support on the Arize platform for generative AI and a first-of-its-kind open source observability library for evaluating large language models (LLMs) at its Arize:Observe 2023 summit.
  • On the other hand, most leading large language models are black boxes that have known issues around hallucination and problematic biases.
  • Available today, Arize Phoenix is the first open source observability library specifically built to help data scientists evaluate outputs from LLMs like OpenAI's GPT-4, Google's Bard, Anthropic's Claude, and others.
  • "Despite calls to halt AI development, the reality is that innovation will continue to accelerate," said Jason Lopatecki, CEO and Co-Founder of Arize AI.

Final Weeks to Register for the 2 Day Lifecycle Management of Analytical Methods and Procedures Course: Current Trends & Your Questions Answered (January 19-20, 2023)

Retrieved on: 
Thursday, January 5, 2023

USP approach for method validation: in-process revisions to Chapters 1200, 1210 and 1225

Key Points: 
  • USP approach for method validation: in-process revisions to Chapters 1200, 1210 and 1225
    Learnings from the new FDA, WHO and PDA method validation guidelines
    Expectations for quality risk assessment, Quality by Design (QbD), Multivariate experiments, system suitability testing, statistics, knowledge management
    Lecture 4 - The lifecycle overview on integrated method development, validation, and ongoing performance verification
    Knowledge management as an important factor in ensuring the acquiring, analyzing, storing and disseminating information
    ICH Q2 validation and test parameters:
    Handling of method changes vs. permitted adjustments

2 Day Lifecycle Management of Analytical Methods and Procedures Course: Current Trends & Your Questions Answered (January 19-20, 2023) - ResearchAndMarkets.com

Retrieved on: 
Monday, December 5, 2022

USP approach for method validation: in-process revisions to Chapters 1200, 1210 and 1225

Key Points: 
  • USP approach for method validation: in-process revisions to Chapters 1200, 1210 and 1225
    Learnings from the new FDA, WHO and PDA method validation guidelines
    Expectations for quality risk assessment, Quality by Design (QbD), Multivariate experiments, system suitability testing, statistics, knowledge management
    Lecture 4 - The lifecycle overview on integrated method development, validation, and ongoing performance verification
    Knowledge management as an important factor in ensuring the acquiring, analyzing, storing and disseminating information
    ICH Q2 validation and test parameters:
    Handling of method changes vs. permitted adjustments
    View source version on businesswire.com: https://www.businesswire.com/news/home/20221205005297/en/

Improved analytic workflows in new version of JMP statistical products

Retrieved on: 
Tuesday, October 18, 2022

CARY, N.C., Oct. 18, 2022 /PRNewswire/ -- While a dairy scientist, a process engineer and a tech innovator have varying domain knowledge, they all rely on the JMP® family of statistical discovery products to meet modern data challenges. JMP 17, JMP Pro 17 and JMP Live 17 are launched today, after first being introduced at the Discovery Summit Americas analytics conference. The products enable scientists and engineers with intuitive and collaborative analytic workflows, whether they are in business to process raw materials into cheese, ensure drug manufacturing meets regulatory standards or develop sensors for autonomous vehicles.

Key Points: 
  • JMP 17, JMP Pro 17 and JMP Live 17 are launched today, after first being introduced at the Discovery Summit Americas analytics conference.
  • JMP 17, JMP Pro 17 and JMP Live 17 launched today after being introduced at the Discovery Summit Americas conference.
  • Consumer products organization Dairygold sees JMP as a process-enabling tool, not just software, explained Science and Analytics Manager Kieran O'Mahony.
  • JMP and all other JMP Statistical Discovery LLC product or service names are registered trademarks or trademarks of JMP Statistical Discovery LLC in the USA and other countries.

Octave Presents Data at the CMSC 2022 Annual Meeting Showing its Multiple Sclerosis Disease Activity Biomarker Test Produces Clinical Practice Population Insights

Retrieved on: 
Friday, June 3, 2022

The data was shared in a poster presentation at the Consortium of Multiple Sclerosis Centers (CMSC) 2022 Annual Meeting.

Key Points: 
  • The data was shared in a poster presentation at the Consortium of Multiple Sclerosis Centers (CMSC) 2022 Annual Meeting.
  • The poster, titled Multivariate Proteomic MS Disease Activity Test Results Surfaces Both Individual Patient and Clinical Practice Population Insights (Qureshi, F., et al.
  • The Octave MSDA test is a novel, clinically-validated biomarker blood test that measures patients disease biology, revealing underlying activated pathways and mechanisms, including quantitative analysis of serum proteins, to create unique MS signatures.
  • Previous data from the company demonstrated that the MSDA test is strongly associated with radiographic and clinical disease activity endpoints.

Octave Presents Clinical Validation Results of its Multivariate Blood-based Multiple Sclerosis Disease Activity Biomarker Test at ACTRIMS Forum 2022

Retrieved on: 
Friday, February 25, 2022

Specific highlights include:

Key Points: 
  • Specific highlights include:
    P018 Clinical Validation Study Results for a Multivariate Proteomic MS Disease Activity Test (Chitnis, T., et al.)
  • P043 Multivariate Proteomic MS Disease Activity Test Result Distributions Based on Disease Modifying Therapy Categories (Chitnis, T., et al.)
  • P006 Analytical Validation of the Disease Activity Score and 4 Disease Pathway Scores for a Multivariate Proteomic Multiple Sclerosis Disease Activity Test (Hu, W., et al.)
  • P044 Multivariate Proteomic MS Disease Activity Test Results Surfaces Both Individual Patient and Clinical Practice Population Insights (Qureshi, F., et al.)

Veritone Delivers the Metaverse to the Global Enterprises With Integration of Synthetic Voice and Conversational AI

Retrieved on: 
Wednesday, November 3, 2021

Veritone, Inc. (NASDAQ: VERI), creator of aiWARE, a hyper-expansive Enterprise AI platform, announced today a fully integrated platform with MARVEL.ais synthetic voice and Veritone-owned Wade & Wendy conversational AI platform.

Key Points: 
  • Veritone, Inc. (NASDAQ: VERI), creator of aiWARE, a hyper-expansive Enterprise AI platform, announced today a fully integrated platform with MARVEL.ais synthetic voice and Veritone-owned Wade & Wendy conversational AI platform.
  • This integration with Veritone MARVEL.ai makes it possible, said Terry Baker, chief executive officer of PandoLogic.
  • We now have an intelligent platform that adds the human touch in recruitment processes and the future metaverse experiences through intelligent conversational AI.
  • Veritone President, Ryan Steelberg , will be speaking at The AI Summit + IoT World Series Silicon Valley about AI applications in the media.

Coveo Acquires Qubit

Retrieved on: 
Friday, October 15, 2021

MONTREAL and NEW YORK and LONDON, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Coveo, a Relevance Platform and applied AI leader that transforms digital experiences with AI-powered search, recommendations, and personalization, today announced the acquisition of Qubit, a leader in AI-powered personalization technology for merchandising teams, based in London, UK, further accelerating Coveo’s geographic expansion into the UK and European markets.

Key Points: 
  • Adding Qubits capabilities to the Coveo Relevance Cloud platform helps us accelerate the delivery of new incremental innovations to further personalize digital commerce experiences, said Louis Ttu, Coveo Chairman and CEO.
  • Approximately 90 Qubit employees will be joining Coveo, bringing the total number of Coveo employees to more than 750 located around the world.
  • Coveo has been named a leader in the Gartner Magic Quadrant for Insight Engines and named a leader in The Forrester Wave: Cognitive Search.
  • Coveo and Qubit are a trademark of Coveo Solutions, Inc.

908 Devices Announces New Data Integrations with Key Industry Partners to Accelerate BioProcess Data Insights

Retrieved on: 
Tuesday, June 22, 2021

With the integration of leading data exploratory tool Sartorius SIMCA and Securecells Lucullus Process Information Management System (PIMS) , users can seamlessly turn REBEL data into deeper actionable insights to drive operational excellence.

Key Points: 
  • With the integration of leading data exploratory tool Sartorius SIMCA and Securecells Lucullus Process Information Management System (PIMS) , users can seamlessly turn REBEL data into deeper actionable insights to drive operational excellence.
  • 908 Devices partnered with Sartorius to allow customers to leverage the multivariate modelling used in SIMCA, which identifies hidden trends and patterns not visible by univariate data analytic methods.
  • Such data mining approaches are enabled with the integration of these two well-known, broadly used software tools.
  • 908 Devices (NASDAQ:MASS) is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications.